Current Concepts Of Diagnosis And Treatment Of Bone And Soft Tissue Tumors

During the past decade, the prognosis of bone and soft tissue tumors has improved considerably. This progress has not only been due to improved therapeutics and diagnostic methods but also due to a team approach now universally adopted. Comparison of results, possible today, were hampered in the past by lack of a clinically relevant staging system and definitive treatment proto cols. The complexity of the therapeutic management of bone tumors re quires a constant exposure to tumors, highly skilled diagnostic tech niques, and specialized expertise. It is therefore not surprising to learn that small and medium-sized hospitals embarking on the diagnosis and treatment of bone and soft tissue tumors are generally less success ful than better equipped major centers. This fact has already been recognized by most physicians and surgeons who now refer their patients to specialized oncologic centers. Nevertheless, they all have to know the present state of the art. This symposium was therefore mostly addressed to them. This international symposium, organized by the Division of Orthopaedic Surgery, University of Ottawa, and cosponsored by the Association des Chirurgiens Orthopedistes du Quebec, was held in Ottawa from May 12-14, 1983. Each of the 40 presentations clearly demonstrates that disregard for proper staging before initiation of treatment and omission of a clearly defined treatment protocol is definitely unacceptable in view of the knowledge we have acquired.

During the past decade, the prognosis of bone and soft tissue tumors has improved considerably. This progress has not only been due to improved therapeutics and diagnostic methods but also due to a team approach now universally adopted. Comparison of results, possible today, were hampered in the past by lack of a clinically relevant staging system and definitive treatment proto cols. The complexity of the therapeutic management of bone tumors re quires a constant exposure to tumors, highly skilled diagnostic tech niques, and specialized expertise. It is therefore not surprising to learn that small and medium-sized hospitals embarking on the diagnosis and treatment of bone and soft tissue tumors are generally less success ful than better equipped major centers. This fact has already been recognized by most physicians and surgeons who now refer their patients to specialized oncologic centers. Nevertheless, they all have to know the present state of the art. This symposium was therefore mostly addressed to them. This international symposium, organized by the Division of Orthopaedic Surgery, University of Ottawa, and cosponsored by the Association des Chirurgiens Orthopedistes du Quebec, was held in Ottawa from May 12-14, 1983. Each of the 40 presentations clearly demonstrates that disregard for proper staging before initiation of treatment and omission of a clearly defined treatment protocol is definitely unacceptable in view of the knowledge we have acquired.

This book reviews the latest techniques for diagnostics and treatments specific to bone and soft tissue tumors. It focuses on imaging and classification of the bone and soft tissue tumors and how histology and cytogenetic aspects can be used to identify tumors. Each chapter focuses on a specific type of tumor, providing a concise overview of relevant information on their characteristics along with the latest surgical and medical treatments available. Bone Tumors: Diagnosis and Therapy Today is a concise guide to successfully identifying and treating bone and soft tissue tumors, making it a valuable resource for practicing medical professionals and trainees who encounter these patients in their day-to-day practice.

Current strategies for addressing the diagnostic and treatment challenges of sarcomas Orthopaedic Oncology: Diagnosis and Treatment is a complete reference for handling the full range of musculoskeletal tumors frequently encountered in the clinical setting, from osseous tumors in the upper extremity, to soft-tissue tumors of the pelvis. The first section presents the principles of initial assessment, guiding the clinician through key questions for developing the differential diagnosis and selecting the imaging modality and surgical technique. The second part of this book presents sarcoma case reports that cover tumor pathologies in different anatomic locations. Each case report contains succinct descriptions of presenting history, differential diagnosis, anatomic and imaging issues, biopsy techniques, pathologic diagnosis and grading, treatment options, surgical details, preferred treatment, pearls, and pitfalls. Features: A comprehensive collection of cases presented according to anatomic location Special emphasis on the significance of a tumor's initial presentation and its implications for surgical treatment Clinical insights for tailoring treatment plans to the patient's particular condition, such as determining when neoadjuvant chemotherapy and adjuvant chemotherapy are indicated Current information about the use of positron emission tomography (PET) for tumor grading Recommendations for avoiding complications and managing potential pitfalls More than 300 images and illustrations that demonstrate key concepts This book is an indispensable resource for orthopedists, oncologists, as well as radiologists and pathology specialists treating patients with bone and soft-tissue tumors.

Bone and soft tissue sarcomas represent only about 2% of all malignancies; however, their treatment – with the goal of curing the patient while preserving the functionality of the affected body part – can, unlike other malignancies, only be successful with therapy concepts devised by interdisciplinary teams. This volume provides an extensive up-to-date overview of the specific diagnostics and current treatment standards of these rare entities, presenting the various limb-sparing modalities for patients with bone and soft tissue sarcomas with special regard to innovative reconstructive options. The evaluation of quality of life based on validated scores and the individual methods of coping with the illness through creative artistic projects are also acknowledged and integrated in the whole concept.

Now fully revised to include recent advances in the field, the second edition of Bone and Soft Tissue Pathology, a volume in the Foundations in Diagnostic Pathology series, is an essential foundation text for residents and pathologists. The popular template format makes it easy to use, and new information throughout brings you up to date with what’s new in the field, including advances in molecular diagnostic testing and new diagnostic biomarkers. Practical and affordable, this resource is ideal for study and review as well as everyday clinical practice. Key features of this practical text include: A consistent, user-friendly format that explores each entity's clinical features, pathologic features (gross and microscopic), ancillary studies, differential diagnoses, and prognostic and therapeutic considerations. A focus on specific features of selected neoplastic and non-neoplastic entities, including broad and in-depth differential diagnoses. Review of normal histology before examining abnormal findings, enabling you to conveniently compare their characteristics in one place at one time. Clinical information on treatment and prognosis, enabling you to better understand the clinical implications of the diagnosis. Nearly 1,000 full-color, high-quality illustrations with extensive figure legends, as well as abundant boxes and tables throughout. What’s NEW in this edition: Advances in molecular diagnostic testing and its capabilities and limitations, including targeted/personalized medicine. New diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities. The latest TNM staging and WHO classification systems. New co-editor Dr. Gunnlaugur Pétur Nielsen of Harvard Medical School joins Dr. Andrew L. Folpe and expert, internationally recognized pathologists who keep you up to date with the latest information in the field.

This volume is a comprehensive guide to the diagnosis and treatment of benign and malignant tumors of the bone and soft tissues. Coverage includes: general issues in diagnosis, staging, surgery, radiation therapy, chemotherapy, and the psychological aspects of patient management. Focus is placed on benign bone tumors, malignant bone tumors, soft-tissue tumors, and carcinoma metastatic to bone. The sections on malignant bone tumors and carcinoma metastatic to bone include detailed guidelines for surgical treatment in each anatomic site. Special features include: considerations for management of malignant bone tumors in growing children; and discussions on the biology and complications of prosthetic and allograft reconstruction.

PLEASE NOTE: Text has been accidentally deleted from page 54 of this book. Please refer to the corrigenda (PDF file) posted on the Stylus Publishing web site or email [email protected] for an updated, printable page. ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Soft Tissue and Bone Tumours is the third volume in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. This volume will be of particular interest to pathologists, oncologists, surgeons, and epidemiologists who manage or research soft tissue and bone tumours. Sections are included on all recognized neoplasms of the soft tissue and bone, as well as on genetic tumour syndromes affecting these sites. Since the previous edition, there have been changes based on recent molecular and genetic information, with impact on clinical practice.